TW312694B - - Google Patents

Download PDF

Info

Publication number
TW312694B
TW312694B TW084109880A TW84109880A TW312694B TW 312694 B TW312694 B TW 312694B TW 084109880 A TW084109880 A TW 084109880A TW 84109880 A TW84109880 A TW 84109880A TW 312694 B TW312694 B TW 312694B
Authority
TW
Taiwan
Prior art keywords
methyl
solvent
pyrimidinyl
residue
solution
Prior art date
Application number
TW084109880A
Other languages
English (en)
Chinese (zh)
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Application granted granted Critical
Publication of TW312694B publication Critical patent/TW312694B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
TW084109880A 1994-09-26 1995-09-19 TW312694B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP22942294 1994-09-26
JP13501095 1995-06-01

Publications (1)

Publication Number Publication Date
TW312694B true TW312694B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1997-08-11

Family

ID=26468965

Family Applications (1)

Application Number Title Priority Date Filing Date
TW084109880A TW312694B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1994-09-26 1995-09-19

Country Status (13)

Country Link
US (1) US5852019A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0784055B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR100388568B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN (1) CN1071754C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE232528T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2201110A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (2) DE69529619T4 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK0784055T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2192584T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI971227L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO313196B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TW (1) TW312694B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO (1) WO1996010024A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6169086B1 (en) 1997-01-27 2001-01-02 Daiichi Pharmaceutical Co., Ltd. Pyrazole derivatives
TW486478B (en) * 1997-01-27 2002-05-11 Daiichi Seiyaku Co Pyrazole derivatives exhibiting anti-tumor effects and a pharmaceutical composition comprising the same
WO2000005230A1 (fr) * 1998-07-24 2000-02-03 Daiichi Pharmaceutical Co., Ltd. Derives de pyrazole et sels correspondants
WO2000043385A1 (fr) * 1999-01-25 2000-07-27 Zenyaku Kogyo Kabushiki Kaisha Composes heterocycliques et agents antitumoraux les comprenant en tant que principe actif
PT1389617E (pt) * 2001-04-27 2007-04-30 Zenyaku Kogyo Kk Composto heterocíclico e agente antitumoral contendo o mesmo como igrediente activo
WO2003011837A1 (en) * 2001-08-01 2003-02-13 Merck & Co., Inc. Tyrosine kinase inhibitors
FR2850379B1 (fr) * 2003-01-28 2006-11-17 Aventis Pharma Sa Produits n-aryl-heteroaromatiques, compositions les contenant et utilisation
CA2512243A1 (fr) * 2003-01-28 2004-09-16 Aventis Pharma S.A. Produits n-aryl-heteroaromatiques, compositions les contenant et utilisation
US20050130989A1 (en) * 2003-01-28 2005-06-16 Aventis Pharma S. A. N-arylheteroaromatic products compositions containing them and use thereof
US7223759B2 (en) * 2003-09-15 2007-05-29 Anadys Pharmaceuticals, Inc. Antibacterial 3,5-diaminopiperidine-substituted aromatic and heteroaromatic compounds
JP4733021B2 (ja) * 2004-03-31 2011-07-27 全薬工業株式会社 複素環式化合物及びそれを有効成分とする抗悪性腫瘍剤
RU2443441C2 (ru) * 2005-03-11 2012-02-27 Зеняку Когио Кабусикикайся Иммунодепрессант и противоопухолевое средство, содержащее гетероциклическое соединение в качестве активного ингредиента
US20070244110A1 (en) * 2006-04-14 2007-10-18 Zenyaku Kogyo Kabushiki Kaisha Treatment of prostate cancer, melanoma or hepatic cancer
ES2430821T3 (es) 2006-10-10 2013-11-21 Amgen Inc. Compuestos de N-arilpirazol para usar contra la diabetes
US10287269B2 (en) * 2015-03-26 2019-05-14 Merck Sharp & Dohme Corp. Pyrazolyl pyrimidinone compounds as PDE2 inhibitors
EP3356345B1 (en) 2015-09-30 2023-11-08 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Heteroaryl derivatives as sepiapterin reductase inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3778433A (en) * 1969-04-18 1973-12-11 Sumitomo Chemical Co Process for producing benzodiazepine derivatives
JPS4842072A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1971-09-29 1973-06-19
JPS61129129A (ja) * 1984-11-28 1986-06-17 Kureha Chem Ind Co Ltd 抗腫瘍剤
US5102893A (en) * 1986-07-07 1992-04-07 Warner-Lambert Company Trans-6-(2-(n-heteroaryl-3,5-disubstituted)pyrazol-4-yl)-ethyl- or ethenyl)tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis

Also Published As

Publication number Publication date
NO313196B1 (no) 2002-08-26
FI971227A7 (fi) 1997-05-23
NO971384D0 (no) 1997-03-24
KR970706275A (ko) 1997-11-03
DE69529619D1 (en) 2003-03-20
NO971384L (no) 1997-05-23
CN1166833A (zh) 1997-12-03
KR100388568B1 (ko) 2003-10-04
ATE232528T1 (de) 2003-02-15
CA2201110A1 (en) 1996-04-04
DK0784055T3 (da) 2003-06-02
EP0784055B1 (en) 2003-02-12
HK1001396A1 (en) 1998-06-19
CN1071754C (zh) 2001-09-26
DE69529619T2 (de) 2003-12-18
FI971227L (fi) 1997-05-23
US5852019A (en) 1998-12-22
FI971227A0 (fi) 1997-03-24
WO1996010024A1 (fr) 1996-04-04
ES2192584T3 (es) 2003-10-16
EP0784055A1 (en) 1997-07-16
EP0784055A4 (en) 1998-01-07
DE69529619T4 (de) 2005-01-27

Similar Documents

Publication Publication Date Title
TW312694B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP0464604B1 (en) 1-Indolylalkyl-4-(alkoxy-pyrimidinyl)piperazines
KR0171598B1 (ko) 부신피질자극호르몬 유리인자(crf) 길항 활성을 가지는 아미노-치환된 피라졸
TW523511B (en) Pharmaceutical composition comprising substituted imidazole compounds and process for preparing compounds
TW454004B (en) Quinoxalinediones
US7183303B2 (en) Gamma-secretase inhibitors
TW200412957A (en) Therapeutic agents
JPH07509726A (ja) Ｃｒｆアンタゴニストとしてのピロロピリミジン
TW200540169A (en) Mtp inhibiting aryl piperidines or piperazines substituted with 5-membered heterocycles
IE903286A1 (en) 3-(1-substituted-4-piperazinyl)-1h-indazoles, a process for¹their preparation and their use as medicaments
HU228457B1 (en) Substituted aza- and diazacycloheptane and cyclooctane derivatives, use thereof, pharmaceutical compositions containing there of
AU2017287553A1 (en) Imidazopyrazinamine phenyl derivative and use thereof
JP7420403B2 (ja) キナーゼ阻害剤として使用される化合物およびその応用
CZ9797A3 (en) Triazole derivative, process of its preparation and pharmaceutical composition containing thereof
TW200838508A (en) Chemical compounds
JPH069618A (ja) ヒドロキシキノロン誘導体
EP0781279A1 (en) Quinoxalinedione nmda receptor antagonists
TW200536539A (en) Organic compounds
US20120095015A1 (en) Triazole compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
US20130085161A1 (en) Piperidinyl substituted 1,3-dihydro-benzoimidazol-2-ylideneamine derivatives
CN101253155B (zh) 11β-羟基类固醇脱氢酶-1-抑制剂-2型糖尿病-1
JPH08225535A (ja) インダゾール誘導体
JPS60214778A (ja) Ν置換３，４−ジヒドロピリミジン誘導体ならびにその製造法および用途
KR100401314B1 (ko) 벤즈이미다졸 유도체 및 그의 약학적으로 허용되는 염
TW382016B (en) 4-[(thien-2yl)methyl]-imidazole analgesics